Coronary Syndrome Clinical Trials

201 recruitingLast updated: July 25, 2026

There are 201 actively recruiting coronary syndrome clinical trials across 48 countries. Studies span Not Applicable, Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1. Top locations include Beijing, Beijing Municipality, China, Seoul, South Korea, Jinan, Shandong, China. Updated daily from ClinicalTrials.gov.


Coronary Syndrome Trials at a Glance

201 actively recruiting trials for coronary syndrome are listed on ClinicalTrialsFinder across 6 cities in 48 countries. The largest study group is Not Applicable with 65 trials, with the heaviest enrollment activity in Beijing, Seoul, and Jinan. Lead sponsors running coronary syndrome studies include Qilu Hospital of Shandong University, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), and Cardiocentro Ticino.

Browse coronary syndrome trials by phase

Treatments under study

About Coronary Syndrome Clinical Trials

Looking for clinical trials for Coronary Syndrome? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Coronary Syndrome trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Coronary Syndrome clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 201 trials

Recruiting
Not Applicable

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions

Arterial Occlusive DiseasesPainCardiovascular Diseases+12 more
Teleflex1,859 enrolled2 locationsNCT07258290
Recruiting

Coronary Laser Atherectomy Registry From an International Taskforce

stable coronary artery diseaseAcute Coronary Syndromes
Ceric Sàrl500 enrolled1 locationNCT07348341
Recruiting
Not Applicable

"Expert IVUS-Eye" vs. IVUS-guided Left Main Bifurcation PCI

Coronary Artery Disease (CAD)Chronic Coronary SyndromeCoronary Bifurcation Lesion+1 more
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health50 enrolled1 locationNCT07711106
Recruiting
Not Applicable

ULTIMATE Study (Carotid Ultrasound Vs CT Coronary Calcium Scoring to Reclassify Symptomatic Patients With Chronic Coronary Syndrome)

Obstructive coronary artery diseaseChronic Coronary Syndrome
London North West Healthcare NHS Trust225 enrolled1 locationNCT07696533
Recruiting
Phase 1

A Trial to Compare What the Body Does to Selatogrel and the Effect of Selatogrel in Chinese Adults With Chronic Coronary Syndrome

Chronic Coronary Syndrome
Viatris Innovation GmbH20 enrolled1 locationNCT07615868
Recruiting
Phase 3

Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Following Coronary Artery Bypass Grafting. (OPTIMUS-CABG Trial)

Chronic Coronary SyndromeStable Coronary Artery Disease CAD
Dolnośląskie Centrum Chorób Serca im.prof. Zbigniewa Religi MEDINET Sp. z o.o.1,703 enrolled18 locationsNCT07195149
Recruiting
Phase 2

A Polypill for Acute Coronary Syndrome

Acute Coronary Syndrome
University of Texas Southwestern Medical Center1,000 enrolled2 locationsNCT07032389
Recruiting
Not Applicable

Revascularization Strategies in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) and Severe Coronary Artery Disease

Acute Coronary SyndromeMultivessel Coronary Artery Disease
American Heart of Poland1,000 enrolled9 locationsNCT01311323
Recruiting
Not Applicable

Effectiveness of a Resilience-Based Rehabilitation Program for Patients With Coronary Heart Disease

Acute Coronary SyndromeTakotsubo CardiomyopathyPsychological resilience
Pensionsversicherungsanstalt130 enrolled1 locationNCT06332859
Recruiting
Not Applicable

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions

Myocardial IschemiaCoronary Artery DiseaseIschemic Heart Disease+3 more
Biotronik AG100 enrolled14 locationsNCT07091682
Recruiting
Early Phase 1

Placebo-controlled Study of Single and Multiple Ascending Doses of UDP-003 in Healthy Human Participants and Followed by an Open-label Patient Cohort

Atherosclerotic Cardiovascular DiseaseAcute Coronary Syndromes
Cyclarity Therapeutics, Inc.84 enrolled1 locationNCT06813339
Recruiting
Phase 1

The Pharmacokinetics and Pharmacodynamics Study of Evategrel CG-0255 Besylate)and Plavix® in Healthy Participants

Peripheral Arterial DiseaseRecent Myocardial InfarctionRecent Stroke+1 more
Shanghai CureGene Pharmaceutical Co., Ltd.136 enrolled1 locationNCT07619885
Recruiting
Phase 4

Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy

Acute Coronary SyndromeMyocardial InfarctionCoronary Artery Disease+1 more
Duk-Woo Park, MD3,320 enrolled45 locationsNCT04416581
Recruiting

Diagnostic Performance of Artificial Intelligence Algorithms in Prediction of Acute Coronary Syndrome Based on White Blood Cell Properties

Acute Coronary SyndromeAngina PectorisSTEMI - ST Elevation Myocardial Infarction+2 more
RobotDreams GmbH3,350 enrolled1 locationNCT06384846
Recruiting
Phase 3

Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes

Acute Coronary Syndrome
Novartis Pharmaceuticals300 enrolled63 locationsNCT07102628
Recruiting
Phase 3

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

Acute Coronary Syndrome
DalCor Pharmaceuticals2,000 enrolled231 locationsNCT05918861
Recruiting
Not Applicable

Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation on Alleviating Major Depressive Disorder in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention:A Prospective, Double-Blind,Randomized Controlled Study

Depressive DisorderPercutaneous Coronary Intervention (PCI)Acute Coronary Syndrome (ACS)+5 more
Jing Han120 enrolled1 locationNCT07454070
Recruiting
Phase 4

Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI

Atrial FibrillationAcute Coronary SyndromeAntithrombotic Therapy+1 more
Medical University of Gdansk1,194 enrolled1 locationNCT04695106
Recruiting
Not Applicable

Oregano and Basil Leaves and Coronary Artery Disease

Acute Coronary SyndromesUnstable Angina (UA)
Shahid Beheshti University of Medical Sciences70 enrolled1 locationNCT07123181
Recruiting
Not Applicable

Predictive Value of Glycemic Parameters Measured With the FSL Pro iQ During ACS

Cardiovascular EventAcute Coronary SyndromeContinuous Glucose Measurement+1 more
University Hospital, Montpellier850 enrolled9 locationsNCT06014112